Zobrazeno 1 - 10
of 117
pro vyhledávání: '"Shigeru Kotake"'
Publikováno v:
Immunological Medicine, Vol 42, Iss 2, Pp 99-102 (2019)
Here we present a 45-year-old male patient who suffered from psoriatic arthritis (PsA), for which adalimumab (80 mg every other week) was effective. Dose escalation of a TNF-α antagonist should be considered for patients showing an inadequate respon
Externí odkaz:
https://doaj.org/article/69fddbd304434f36a980a90dc65193be
Autor:
Tsuyoshi Kobashigawa, Yuki Nanke, Masakazu Takazoe, Kuniko Iihara, Hisashi Yamanaka, Shigeru Kotake
Publikováno v:
Clinical Medicine Insights: Case Reports, Vol 2014, Iss 7, Pp 13-19 (2014)
Externí odkaz:
https://doaj.org/article/8680c6761b794ee4bdcd2a08896b22d9
Publikováno v:
Pharmaceuticals, Vol 3, Iss 5, Pp 1394-1410 (2010)
Osteoclasts play a critical role in both normal bone metabolism and bone resorption in the joints of patients with rheumatoid arthritis. It has been reported that non-steroidal anti-inflammatory drugs (NSAIDs) inhibit murine osteoclastogenesis in vit
Externí odkaz:
https://doaj.org/article/4796d7a15d6d4892b0e3881d16c8ca4b
Inhibitory effects of zinc hyaluronate on synoviocyte growth and matrix metalloproteinase-9 activity
Publikováno v:
Journal of Inflammation Research, Vol 2009, Iss default, Pp 45-57 (2009)
Seiji Saito, Keisei Maekawa, Shigeru KotakeInstitute of Rheumatology, Tokyo Women’s Medical University, Tokyo, JapanAbstract: Sodium hyaluronate (Na-HA) is a therapeutic agent used for treating knee arthritis. However, it has been unsuccessfully us
Externí odkaz:
https://doaj.org/article/d9e3084f9bd74caba0437ca97f4471e9
Autor:
Eri Watanabe, Yohei Sugiyama, Hiroaki Sato, Toshiyuki Imanishi, Akinari Fukuda, Kenjiro Takagi, Tomoyuki Asano, Kiyoshi Migita, Toshihiro Nanki, Shigeru Kotake
Publikováno v:
Modern Rheumatology Case Reports. 6:260-265
Adult-onset Still’s disease (AOSD) is a rare systemic inflammatory disorder of unknown aetiology that is categorised as a non-hereditary disease. Neonatal haemophagocytic lymphohistiocytosis (HLH) is also a rare, but potentially fatal condition. Ne
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d0984f5cd6e5c42a024fb566f72e3dd
https://doi.org/10.1093/mrcr/rxab035
https://doi.org/10.1093/mrcr/rxab035
Publikováno v:
Rheumatology. 60:322-332
Objectives Galectin-3 is involved in various biological activities, including immune activations and fibrosis. Idiopathic inflammatory myopathies (IIMs) are autoimmune diseases of unknown aetiology, often complicated by interstitial lung disease (ILD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7600c9bfb8a87b05c977721bdfa4864
https://doi.org/10.1093/rheumatology/keaa305
https://doi.org/10.1093/rheumatology/keaa305
Autor:
Tsuyoshi Kobashigawa, Hiroki Yabe, Yusuke Ozeki, Eri Watanabe, Takahiko Fukuchi, Hiroshi Hori, Toru Yago, Shigeru Kotake, Kazusige Futsuhara, Akira Tanaka, Hitoshi Sugawara
Publikováno v:
Modern Rheumatology Case Reports. 5:62-68
A 71-year-old woman with dermatomyositis (DM) received glucocorticoid steroid (GCS) and tacrolimus treatment. Relapse of skin symptoms was observed after tapering the GCS dose, and the patient tested positive for anti-transcriptional intermediary fac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b84b25d46453ee3f81c04b2c8b8c5dc3
https://doi.org/10.1080/24725625.2020.1789302
https://doi.org/10.1080/24725625.2020.1789302
Publikováno v:
Immunological Medicine, Vol 42, Iss 2, Pp 99-102 (2019)
Here we present a 45-year-old male patient who suffered from psoriatic arthritis (PsA), for which adalimumab (80 mg every other week) was effective. Dose escalation of a TNF-α antagonist should be considered for patients showing an inadequate respon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c05fbd13c883a79c5f921f9b4fda3487
https://doaj.org/article/69fddbd304434f36a980a90dc65193be
https://doaj.org/article/69fddbd304434f36a980a90dc65193be
Publikováno v:
Modern Rheumatology Case Reports. 3:38-44
Behcet’s disease (BD) is a systemic inflammatory disorder and involvement of the bowel leads to a poor prognosis due to perforation of intestinal ulcers and penetration of ulceration into surrounding organs. We describe the clinical features of 4 J
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f46eea3690e78859edf9c27967ace7af
https://doi.org/10.1080/24725625.2018.1449291
https://doi.org/10.1080/24725625.2018.1449291